CAR T-Cell Therapy: A Healthcare Professional s Guide – Cancer Targets
CAR T-Cell Therapy: A Healthcare Professional’s Guide – Cancer Targets The very first investigational oncology gene therapy known as a chimeric antigen receptor (CAR) T-cell therapy is now FDA approval. These agents — by all means an bioengineering miracle — are constructed from the patient’s own T lymphocytes to escalate their cancer-killing capability, and then…